Roche Holding AG
RHHBY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.17 | -0.37 | 0.18 | -0.29 |
| FCF Yield | 1.31% | 4.90% | 3.12% | 2.69% |
| EV / EBITDA | 35.96 | 38.61 | 21.85 | 31.07 |
| Quality | ||||
| ROIC | 5.72% | 7.11% | 9.83% | 8.34% |
| Gross Margin | 75.67% | 72.43% | 75.71% | 67.37% |
| Cash Conversion Ratio | 0.96 | 5.79 | 1.26 | 3.63 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.46% | 0.21% | 0.05% | 0.40% |
| Free Cash Flow Growth | -72.56% | 59.56% | 18.33% | -6.81% |
| Safety | ||||
| Net Debt / EBITDA | 4.15 | 4.91 | 2.98 | 3.59 |
| Interest Coverage | 20.87 | 12.91 | 14.51 | 14.04 |
| Efficiency | ||||
| Inventory Turnover | 0.51 | 1.11 | 0.94 | 1.07 |
| Cash Conversion Cycle | 139.02 | 78.26 | 83.21 | 84.02 |